Answer
Evolocumab should be used with caution in patients with severe hepatic impairment (Child-Pugh class C), as these patients have not been studied.
Sources for this answer
- Repatha SureClickAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked